Andrew Gottesdiener's Insider Trades & SAST Disclosures

Andrew Gottesdiener's most recent trade in Apogee Therapeutics Inc. was a trade of 14,461 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Apogee Therapeutics Inc.
Andrew Gottesdiener Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2025 14,461 14,461 - - Stock Option (Right to Buy)
Apogee Therapeutics Inc.
Andrew Gottesdiener Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 10,370 10,370 - - Stock Option (Right to Buy)
Apogee Therapeutics Inc.
Andrew Gottesdiener Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2023 47,758 47,758 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades